Intimal Sarcoma of the Pulmonary Artery Treated with Pazopanib
Author:
Affiliation:
1. Respiratory Medicine, National Hospital Organization Tokyo Medical Center, Japan
2. Pathology, National Hospital Organization Tokyo Medical Center, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/55/16/55_55.6199/_pdf
Reference12 articles.
1. 1. Blackmon SH, Rice DC, Correa AM, et al. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87: 977-984, 2009.
2. 2. Pop O, Pirvu A, Toffart AC, Moro-Sibilot D. Disease flare after treatment discontinuation in a patient with EML4-ALK lung cancer and acquired resistance to crizotinib. J Thorac Oncol 7: e1-e2, 2012.
3. 3. Chaft JE, Oxnard GR, Sima CS, Kris MG, Miller VA, Riely GJ. Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design. Clin Cancer Res 17: 6298-6303, 2011.
4. 4. Kim YH, Fukuhara A, Mishima M. Should epidermal growth factor receptor-tyrosine kinase inhibitor be continued beyond progressive disease? Case Rep Oncol 4: 470-474, 2011.
5. 5. Chen X, Ren S, Li A, Zhou C. A case report of chemo-sensitive intimal pulmonary artery sarcoma. Cell Biochem Biophys 68: 153-157, 2014.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of pulmonary endarterectomy for patients with pulmonary artery sarcoma;Frontiers in Cardiovascular Medicine;2024-07-02
2. Case report: Navigating treatment pathways for cardiac intimal sarcoma with PDGFRβ N666K mutation;Frontiers in Oncology;2024-04-05
3. Pulmonary artery intimal sarcoma: A rare cause of filling defects in pulmonary arteries;The American Journal of the Medical Sciences;2022-11
4. Rare case of pulmonary artery intimal sarcoma managed by pneumonectomy;ANZ Journal of Surgery;2022-02-21
5. Pulmonary artery sarcoma: An important mimic of pulmonary embolism—Case reports and literature review;Respirology Case Reports;2022-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3